The hemoregulatory peptide N-acetyl-ser-asp-lys-pro impairs angiotensin I-induced contractions in rat aorta

Eur J Pharmacol. 1998 Dec 18;363(2-3):153-6. doi: 10.1016/s0014-2999(98)00820-6.

Abstract

The hemoregulatory peptide N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) is degraded by ACE. This study was designed to examine the effect of Ac-SDKP on the contractions to angiotensin I. Experiments were performed on rat aortic rings with endothelium exposed to nitro-L-arginine. Ac-SDKP (10 and 100 microM) significantly augmented angiotensin I ED20 (from 2.0+/-0.4 to 4.2+/-1.0 and 5.0+/-0.9 nM) and ED50 (from 4.3+/-0.7 to 8.6+/-1.0 and 10.7+/-1.3 nM, respectively), but did not alter its maximal response. The contractions to angiotensin II were not affected by Ac-SDKP. No degradation of exogenous Ac-SDKP nor detectable release of endogenous Ac-SDKP were observed in the incubation medium. These results suggest that Ac-SDKP impairs angiotensin I response by inhibiting ACE and subsequent angiotensin II formation.

MeSH terms

  • Angiotensin I / metabolism
  • Angiotensin I / pharmacology*
  • Angiotensin II / metabolism
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Animals
  • Aorta
  • Drug Interactions
  • In Vitro Techniques
  • Male
  • Oligopeptides / pharmacology*
  • Rats
  • Rats, Wistar
  • Vasoconstriction / drug effects*

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Oligopeptides
  • Angiotensin II
  • Angiotensin I
  • goralatide